Trial Profile
Second phase 1 study of denibulin [MN 029] in patients with advanced metastatic solid tumours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Denibulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 16 Dec 2015 New trial record
- 14 Dec 2015 Results published in MediciNova media release.